MARQUITTA BROWN: Open Payments
NPI 1669844775 · SHREVEPORT, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$456 in 22 payments from 13 companies in 2025. Trend: 2023 $483 · 2024 $503 · 2025 $456
Food & beverage: $456
| Company | Payments | Amount |
|---|---|---|
| Corcept Therapeutics | 3 | $90 |
| Insulet Corporation | 4 | $77 |
| Amgen Inc. | 3 | $66 |
| Pharmacosmos Therapeutics Inc. | 2 | $35 |
| Incyte Corporation | 2 | $32 |
| Medtronic, Inc. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $21 |
| Sequel Med Tech, LLC | 1 | $21 |
| Tandem Diabetes Care, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $20 |
Products named: Korlym, Omnipod, TEPEZZA, MONOFERRIC, JAKAFI, MINIMED 780G, TZIELD, TWIIST.
Industry payments across LA — which companies pay providers there.
